Nutreco

ViAqua Therapeutics Ltd is an innovative biotechnology company based in Misgav, Israel, focused on developing therapeutics for the aquaculture industry. Founded in 2014, ViAqua is pioneering an orally administered particle-based platform that aims to prevent viral epidemics affecting aquatic species. The company utilizes a proprietary RNAi nanoparticle formulation that activates a cellular response to disable viral infections. This technology enables the delivery of coated nanoparticles through feed or immersion, significantly enhancing the resistance of shrimp and other aquaculture species to viral diseases. With a management team possessing extensive experience in business development and industrial biotechnology, ViAqua Therapeutics is positioned to make a substantial impact on the health and sustainability of aquaculture practices.

ViAqua Therapeutics Ltd is an innovative biotechnology company based in Misgav, Israel, focused on developing therapeutics for the aquaculture industry. Founded in 2014, ViAqua is pioneering an orally administered particle-based platform that aims to prevent viral epidemics affecting aquatic species. The company utilizes a proprietary RNAi nanoparticle formulation that activates a cellular response to disable viral infections. This technology enables the delivery of coated nanoparticles through feed or immersion, significantly enhancing the resistance of shrimp and other aquaculture species to viral diseases. With a management team possessing extensive experience in business development and industrial biotechnology, ViAqua Therapeutics is positioned to make a substantial impact on the health and sustainability of aquaculture practices.

West Coast Salmon plans to build and operate an industrial scale.

BlueNalu, Inc. is a cellular aquaculture company based in San Diego, California, founded in 2017. The company specializes in processing and producing cell-based seafood products by culturing fish tissue from cells, thereby addressing the global demand for seafood while promoting sustainability and reducing overfishing. BlueNalu offers a range of healthy, safe, and high-quality seafood options that support the diversity of ocean ecosystems. Its innovative approach allows for the creation of fresh and frozen seafood products that are free from plastics, pathogens, toxins, and other contaminants, catering to restaurants and consumers seeking trusted seafood alternatives.

ViAqua Therapeutics Ltd is an innovative biotechnology company based in Misgav, Israel, focused on developing therapeutics for the aquaculture industry. Founded in 2014, ViAqua is pioneering an orally administered particle-based platform that aims to prevent viral epidemics affecting aquatic species. The company utilizes a proprietary RNAi nanoparticle formulation that activates a cellular response to disable viral infections. This technology enables the delivery of coated nanoparticles through feed or immersion, significantly enhancing the resistance of shrimp and other aquaculture species to viral diseases. With a management team possessing extensive experience in business development and industrial biotechnology, ViAqua Therapeutics is positioned to make a substantial impact on the health and sustainability of aquaculture practices.